Background There is no clear cut way to predict exactly which superficial urothelial carcinomas would subsequently not recur, which tumours would subsequently recur or progress after initial resection of the tumours. There is also no accurate way of predicting the outcome of muscle-invasive tumours urothelial following treatment Aims (a) To confirm the suggestion that aneuploidy is more common ...

to determine the addition of value of neoadjuvant, concurrent and adjuvant chemotherapy to radiation in the treatment of nasopharyngeal carcinoma with regard to the overall survival (os) and disease free survival (dfs) within a six year period in tehran cancer institute. files of all patients with nasopharyngeal carcinoma treated by radiotherapy with or without concurrent chemotherapy in a cura...

leiomyosarcoma is a rare entity in prostate but it is the most common type of prostate sarcomas in adult patients. in most reported series the prognosis is poor and the median survival is about 15-18 months. hereby we present a 72 years old man who received combined modality treatment including radical surgery followed by adjuvant chemotherapy and radiotherapy. he has been well for 14 months, b...

Abstract Herein, we present the case of a 58 y–o Caucasian man with unremarkable cardiovascular history and strong family for cancer. He was diagnosed lung adenocarcinoma IVb (pleura, pleural effusion, lymph nodes), PDL1: 2% TPS absence actionable driver mutations on DNA RNA NGS (only ERBB2 mutation). Started first–line chemotherapy cisplatin–pemetrexed regimen immunotherapy pembrolizumab. deve...